HSR20-077: Determinants of Time to Treatment Initiation in Metastatic Cancers

Authors:
Christopher Black Merck & Co., Inc., Kenilworth, NJ

Search for other papers by Christopher Black in
Current site
Google Scholar
PubMed Close
 PhD
,
Weilin Meng Merck & Co., Inc., Boston, MA

Search for other papers by Weilin Meng in
Current site
Google Scholar
PubMed Close
 MS
, and
Srinivasan Rajagopalan Med Data Analytics, Inc., Milltown, NJ

Search for other papers by Srinivasan Rajagopalan in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 18: Issue 3.5
Online Publication Date:
20 Mar 2020
DOI:
https://doi.org/10.6004/jnccn.2019.7433
Restricted access

Corresponding Author: Christopher Black, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2020 by the National Comprehensive Cancer Network 2020
Article Category:
Abstract
Print Publication Date:
20 Mar 2020
Online Publication Date:
20 Mar 2020

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 702 220 64
PDF Downloads 346 0 0
EPUB Downloads 0 0 0